ERBB2 and breast cancer: Gene deletion of AKT1 resulted in reduced cellular migration in vitro, reduced metastasis of HER2-induced breast cancers, and reduced phosphorylation of the tumor suppressor tuberous sclerosis complex 2 (TSC2) in a murine in vivo model [63].